Key points are not available for this paper at this time.
This study demonstrated the potential utility of molecular-structural mismatch indexes for noninvasive risk stratification of individuals with pediatric neuroblastoma, which would allow for more precise and personalized therapy.
Wen et al. (Fri,) studied this question.